Walmart Inc. (WMT)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	785,991	788,557	444,892	387,989	387,816	397,486
Market Cap Growth	62.66%	77.25%	14.67%	0.04%	-2.43%	22.37%
Enterprise Value	845,373	848,443	511,073	452,544	438,666	458,434
Last Close Price	98.49	97.66	54.15	46.44	44.43	43.95
PE Ratio	42.09	40.57	28.68	33.22	28.36	29.42
Forward PE	36.96	36.96	24.21	22.76	21.06	24.69
PS Ratio	1.15	1.16	0.69	0.64	0.68	0.71
PB Ratio	9.39	8.07	4.91	4.62	4.22	4.54
P/TBV Ratio	14.31	13.66	8.61	8.77	7.84	8.45
P/FCF Ratio	58.17	62.29	29.42	32.38	35.02	15.40
P/OCF Ratio	20.90	21.64	12.45	13.45	16.04	11.02
PEG Ratio	4.67	3.81	3.30	4.40	2.29	3.05
EV/Sales Ratio	1.23	1.25	0.79	0.74	0.77	0.82
EV/EBITDA Ratio	19.77	20.10	13.15	12.76	11.99	13.60
EV/EBIT Ratio	28.62	29.01	18.92	18.45	16.91	20.33
EV/FCF Ratio	62.56	67.02	33.80	37.76	39.61	17.76
Debt / Equity Ratio	0.76	0.64	0.70	0.73	0.64	0.73
Debt / EBITDA Ratio	1.48	1.36	1.50	1.58	1.47	1.72
Debt / FCF Ratio	5.08	4.91	4.18	5.09	5.28	2.47
Asset Turnover	2.65	2.65	2.62	2.51	2.30	2.29
Inventory Turnover	9.12	9.19	8.79	8.20	8.46	9.40
Quick Ratio	0.19	0.20	0.20	0.18	0.26	0.26
Current Ratio	0.78	0.82	0.83	0.82	0.93	0.97
Return on Equity (ROE)	21.78%	21.41%	18.64%	12.84%	15.54%	16.21%
Return on Assets (ROA)	7.15%	7.12%	6.81%	6.28%	6.52%	5.76%
Return on Capital (ROIC)	11.75%	11.66%	11.30%	10.38%	10.76%	9.21%
Return on Capital Employed (ROCE)	18.50%	17.80%	16.90%	16.20%	16.50%	14.10%
Earnings Yield	2.39%	2.46%	3.49%	3.01%	3.53%	3.40%
FCF Yield	1.72%	1.60%	3.40%	3.09%	2.86%	6.49%
Dividend Yield	0.96%	0.85%	1.40%	1.61%	1.65%	1.64%
Payout Ratio	38.99%	34.41%	39.59%	52.35%	44.99%	45.27%
Buyback Yield / Dilution	0.35%	0.33%	1.15%	2.53%	1.47%	0.73%
Total Shareholder Return	1.30%	1.18%	2.55%	4.14%	3.13%	2.37%

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q